Findings

What do systematic reviews say?

31 questions · 43 findings · 3 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 9 · 20.9%GRADE not reported 0 · 0%Very low 14 · 32.6%Low 7 · 16.3%Moderate 13 · 30.2%High 0 · 0%

DHEA or testosterone vs placebo/no treatment

Miscarriage rate ‐ DHEA · women undergoing assisted reproduction

DHEA or testosterone showed no clear difference in miscarriage rate ‐ DHEA compared with placebo/no treatment (moderate certainty).

1 finding from 1 review

Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction 2015 · Cochrane Headline outcomes only
OR 0.58 [0.29, 1.17]
8 studies · 950 participants
Moderate

DHEA or testosterone vs placebo/no treatment

Clinical pregnancy rate · women undergoing assisted reproduction

DHEA or testosterone probably leads to higher clinical pregnancy rate ‐ DHEA compared with placebo/no treatment (moderate certainty).

1 finding from 1 review

Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction 2015 · Cochrane Headline outcomes only
OR 1.34 [1.01, 1.76]
12 studies · 1246 participants
Moderate

Testosterone vs placebo

Sexual satisfaction · Men with COPD

1 finding from 1 review

Interventions for sexual dysfunction in people with chronic obstructive pulmonary disease (COPD) 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 24 participants
Low

Testosterone vs placebo

Effect on later sexual function · Men with COPD

1 finding from 1 review

Interventions for sexual dysfunction in people with chronic obstructive pulmonary disease (COPD) 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 24 participants
Low

Testosterone vs placebo

Adverse events (all cause) · Men with COPD

Testosterone therapy showed no clear difference in adverse events (all cause) compared with placebo (low certainty).

1 finding from 1 review

Interventions for sexual dysfunction in people with chronic obstructive pulmonary disease (COPD) 2015 · Cochrane Headline outcomes only
RR 1.07 [0.07, 15.54]
1 study · 29 participants
Low

Testosterone as an add‐on to PDE5I vs PDE5I

Erectile function · men with sexual dysfunction

1 finding from 1 review

Testosterone replacement in men with sexual dysfunction 2024 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 430 participants
Low

Testosterone as an add‐on to PDE5I vs PDE5I

Sexual quality of life · men with sexual dysfunction

1 finding from 1 review

Testosterone replacement in men with sexual dysfunction 2024 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 282 participants
Low

Testosterone as an add‐on to PDE5I vs PDE5I

Cardiovascular mortality · men with sexual dysfunction

The review found no eligible studies for this question.

1 finding from 1 review

Testosterone replacement in men with sexual dysfunction 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Testosterone as an add‐on to PDE5I vs PDE5I

Withdrawals due to adverse events · men with sexual dysfunction

Testosterone as an add‐on to PDE5I showed no clear difference in treatment withdrawal due to adverse events compared with PDE5I alone (low certainty).

1 finding from 1 review

Testosterone replacement in men with sexual dysfunction 2024 · Cochrane Headline outcomes only
RR 1.26 [0.32, 4.91]
3 studies · 388 participants
Low

Testosterone as an add‐on to PDE5I vs PDE5I

Prostate‐related events · men with sexual dysfunction

It is very uncertain whether testosterone as an add‐on to PDE5I changes prostate‐related events compared with PDE5I alone (very low certainty).

1 finding from 1 review

Testosterone replacement in men with sexual dysfunction 2024 · Cochrane Headline outcomes only
RR 6.83 [0.84, 55.37]
3 studies · 373 participants
Very low

Testosterone as an add‐on to PDE5I vs PDE5I

Lower urinary tract symptoms · men with sexual dysfunction

The review found no eligible studies for this question.

1 finding from 1 review

Testosterone replacement in men with sexual dysfunction 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found